Data privacy in telemedicine has been extensively considered and reviewed in the literature, such as explorations of consent, who can access information, and the security of electronic systems. However, privacy breaches are also a potential concern in the physical setting and surroundings of the patient. Here we review clinical situations in which there is unanticipated loss of privacy, as well as potential physical and psychological safety concerns for the patient and others when privacy is limited. We identify ethical concerns and explore the challenges of supporting full true autonomous decision-making in this situation. We close with preliminary recommendations at the patient, clinician, and systems levels to help ensure privacy is maintained.
SmithACThomasESnoswellCL, et al.Telehealth for global emergencies: implications for coronavirus disease 2019 (COVID-19). J Telemed Telecare2020; 26: 309–313.
2.
ThomasEEHaydonHMMehrotraA, et al.Building on the momentum: sustaining telehealth beyond COVID-19. J Telemed Telecare2022; 28: 301–308.
3.
SnoswellCLChelbergGDe GuzmanKR, et al.The clinical effectiveness of telehealth: a systematic review of meta-analyses from 2010 to 2019. J Telemed Telecare2021: 1–16. Published online 2021:1357633X2110229. doi:10.1177/1357633x211022907
4.
SnoswellCLStringerHTaylorML,et al.An overview of the effect of telehealth on mortality: a systematic review of meta-analyses. J Telemed Telecare2021: 1–10. Published online 2021. doi:10.1177/1357633X211023700
5.
CheungSGCapoteJFanW,et al.Pilot assessment of patient and provider characteristics associated with satisfactory consultation-liaison telepsychiatry encounters. J Acad Consult Liaison Psychiatry2021; 62: 582–587.
6.
MishkinADCheungSCapoteJ,et al.Survey of Clinician Experiences of Telepsychiatry and Tele-Consultation-Liaison Psychiatry. J Acad Consult Liaison Psychiatry2021; 63: 334–344.
7.
GuinartDMarcyPHauserM,et al.Mental health care Providers’ attitudes toward telepsychiatry: a systemwide, multisite survey during the COVID-19 pandemic. Psychiatr Serv2021; 72: 704–707.
8.
KhoongECSharmaAEGuptaK,et al.The Abrupt Expansion of Ambulatory Telemedicine: implications for Patient Safety. J Gen Intern Med2022; 37: 1270–1274.
9.
LadinKPortenyTPeruginiJM, et al.Perceptions of telehealth vs in-person visits among older adults with advanced kidney disease, care partners, and clinicians. JAMA Netw Open2021; 4: e2137193.
10.
HeyerAGranbergRERisingKL,et al.Medical oncology Professionals’ perceptions of telehealth video visits. JAMA Netw Open2021; 4: e2033967.
11.
PotkinMMishkinACheungS, et al.A thematic coded analysis of clinicians’ experiences providing Telepsychiatry during the COVID pandemic. Unpublished data.
12.
Uscher-PinesLSousaJRajaP,et al.Suddenly becoming a “virtual doctor”: experiences of psychiatrists transitioning to telemedicine during the COVID-19 pandemic. Psychiatr Serv2020; 71: 1143–1150.
13.
BerkeyFJWiedemerJPVithalaniND. Delivering bad or life-altering news. Am Fam Physician2018; 98: 99–104.
14.
LunshofJEChadwickRVorhausDB,et al.From genetic privacy to open consent. Nat Rev Genet2008; 9: 406–411.
15.
RingheimK. Ethical and human rights perspectives on providers’ obligation to ensure adolescents’ rights to privacy. Stud Fam Plann2007; 38: 245–252.
16.
FordCAMillsteinSGHalpern-FelsherBL,et al.Influence of physician confidentiality assurances on adolescents’ willingness to disclose information and seek future health care. A randomized controlled trial. JAMA1997; 278: 1029–1034.
17.
Broaddus-SheaETScottKReijndersM,et al.A review of the literature on good practice considerations for initial health system response to child and adolescent sexual abuse. Child Abuse Negl2021; 116: 104225.
WaalenJGoodwinMMSpitzAM,et al.Screening for intimate partner violence by health care providers. Barriers and interventions. Am J Prev Med2000; 19: 230–237.
20.
SzlykHSBerkMPeraltaAO,et al.COVID-19 Takes adolescent suicide prevention to less charted territory. J Adolesc Health2020; 67: 161–163.
21.
BrennaCTLinksPSTranMM,et al.Innovations in suicide assessment and prevention during pandemics. Public Health Res Pract2021; 31: 1–4.
22.
LuxtonDDO'BrienKPruittLD,et al.Suicide risk management during clinical telepractice. Int J Psychiatry Med2014; 48: 19–31.
23.
LandsbergerHA. Interaction process analysis of the mediation of labor-management disputes. J Abnorm Psychol1955; 51: 552–558.
24.
Robins WahlinTB. To know or not to know: a review of behaviour and suicidal ideation in preclinical huntington's disease. Patient Educ Couns2007; 65: 279–287.
25.
CoustasseAPekarASikulaA,et al.Ethical considerations of genetic presymptomatic testing for huntington's disease. J Hosp Mark Public Relations2009; 19: 129–141.
26.
HannaJRMcCaughanESempleCJ. Challenges and support needs of parents and children when a parent is at end of life: a systematic review. Palliat Med2019; 33: 1017–1044. Epub 2019 Jun 27. PMID: 31244381.
27.
BariAKhanRARathoreAW. Postgraduate residents’ perception of the clinical learning environment; use of postgraduate hospital educational environment measure (PHEEM) in Pakistani context. J Pak Med Assoc2018; 68: 417–422.
HeymannWR. Assessing the competence of aging physicians who are young at heart. JAMA Dermatol2018; 154: 875–876.
30.
JonesJWMcCulloughLB. The question of an impaired surgeon dilemma. J Vasc Surg2012; 56: 1761–1762.
31.
DavisJK. Conscientious refusal and a doctors’s right to quit. J Med Philos2004; 29: 75–91.
32.
RichardCLajeunesseYLussierMT. Therapeutic privilege: between the ethics of lying and the practice of truth. J Med Ethics2010; 36: 353–357.
33.
Public Law. 114–255: An act to accelerate the discovery, development, and delivery of 21st century cures, and for other purposes. (2016).
34.
Bioethics Co. Policy statement--physician refusal to provide information or treatment on the basis of claims of conscience. Pediatrics2009; 124: 1689–1693.
35.
CaldwellJTFordCLWallaceSP,et al.Intersection of living in a rural versus urban area and race/ethnicity in explaining access to health care in the United States. Am J Public Health2016; 106: 1463–1469.
